The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Mardi Gomberg-Maitland

University of Chicago Medical Center

Chicago

Illinois 60611

USA

[email]@*.bsd.uchicago.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University of Chicago Medical Center, Chicago, Illinois 60611, USA. 2005 - 2011
  • Section of Cardiology, Department of Medicine, University of Chicago, Chicago, USA. 2007 - 2010
  • University of Chicago Medical Center, Section of Cardiology, MC2016, 5841 S. Maryland Ave., USA. 2008
  • Department of Medicine, Section of Cardiology, University of Chicago Hospitals, University of Chicago, USA. 2006
  • Advanced Heart Failure and Pulmonary Hypertension Program, University of Chicago Hospitals, Chicago, IL 60637, USA. 2005
  • Division of Cardiology, University of Chicago Hospitals, IL 60637, USA. 2005

References

  1. Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective. Gomberg-Maitland, M., Dufton, C., Oudiz, R.J., Benza, R.L. J. Am. Coll. Cardiol. (2011) [Pubmed]
  2. A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension. Gomberg-Maitland, M., Maitland, M.L., Barst, R.J., Sugeng, L., Coslet, S., Perrino, T.J., Bond, L., Lacouture, M.E., Archer, S.L., Ratain, M.J. Clin. Pharmacol. Ther. (2010) [Pubmed]
  3. United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR). Gomberg-Maitland, M., Thenappan, T., Rizvi, K., Chandra, S., Meads, D.M., McKenna, S.P. J. Heart Lung Transplant. (2008) [Pubmed]
  4. Traditional and alternative designs for pulmonary arterial hypertension trials. Gomberg-Maitland, M. Proc. Am. Thorac. Soc (2008) [Pubmed]
  5. Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension. Gomberg-Maitland, M., Huo, D., Benza, R.L., McLaughlin, V.V., Tapson, V.F., Barst, R.J. J. Heart Lung Transplant. (2007) [Pubmed]
  6. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Gomberg-Maitland, M., Wenger, N.K., Feyzi, J., Lengyel, M., Volgman, A.S., Petersen, P., Frison, L., Halperin, J.L. Eur. Heart J. (2006) [Pubmed]
  7. Are we appropriately triaging patients with unstable angina?. Gomberg-Maitland, M., Murphy, S.A., Moliterno, D.J., Cannon, C.P. Am. Heart J. (2005) [Pubmed]
  8. Prostacyclin therapy for pulmonary arterial hypertension: new directions. Gomberg-Maitland, M., Preston, I.R. Semin. Respir. Crit. Care. Med (2005) [Pubmed]
  9. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. Gomberg-Maitland, M., Tapson, V.F., Benza, R.L., McLaughlin, V.V., Krichman, A., Widlitz, A.C., Barst, R.J. Am. J. Respir. Crit. Care Med. (2005) [Pubmed]
  10. Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension. Gomberg-Maitland, M., McLaughlin, V., Gulati, M., Rich, S. Am. J. Cardiol. (2005) [Pubmed]
 
WikiGenes - Universities